Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
Prediction Markets
Private Markets
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Pressure BioSciences Inc Stock News

PBIOOTCEM

Trade with Public

Trade with Public

$0.00060

Last update: Nov 10, 8:42 AM

OverviewNewsInsider Trades Short Interest

Latest Pressure BioSciences Stock News | OTC:PBIO | Benzinga

Get the latest news on Pressure BioSciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Pressure BioSciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, January 16, 2024

Toni Braxton Cheers PBIO's Acquisition Of CBD Co. Uncle Bud's (UPDATED)
Javier Hasse

Tuesday, July 25, 2023

CBD To Extend Shelf-Life Of Fresh Produce? This Company Is Working On It
Vuk Zdinjak

Thursday, March 16, 2023

Isiah Thomas: From NBA Champ To Business Mogul, Hemp Cars, CBD Drinks & Champagne Producer
Jelena Martinovic

Friday, January 27, 2023

These Companies Teamed Up To Develop CBD-Nanoemulsion Sports Performance/Recovery Drinks
Vuk Zdinjak

Thursday, January 19, 2023

Is Getting High In 10 Minutes Without The Respiratory Health Risks Possible? Company Clams It Is With New THC Oral Spray
Vuk Zdinjak

Wednesday, August 24, 2022

EXCLUSIVE: Pressure BioSciences Inks Cosmeceuticals Partnership Using Nano Emulsification Platform
Vandana Singh

Thursday, August 12, 2021

EXCLUSIVE: Pressure BioSciences Wins $1M Purchase Order For Agrochem Products
Vandana Singh
EXCLUSIVE: Pressure BioSciences Reports Its PBI Agrochem Subsidiary Received Initial Purchase Orders For $1M+ Of Eco-Friendly Agrochemical Products For Delivery In 2021
Zoltan Suranyi

Tuesday, July 13, 2021

Water-Soluble CBD With One Year Stability Has Been Achieved By Pressure BioSciences' Technology Representing 'Explosive Growth Opportunity'
Nina Zdinjak
PRO
EXCLUSIVE: Pressure BioSciences Reports Proce...
Benzinga Newsdesk

Wednesday, December 07, 2016

Karyopharm Therapeutics CEO And CFO Talk Company Finances, Partnerships And Pipeline
Benzinga

Tuesday, December 06, 2016

Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important'
Benzinga

Monday, December 05, 2016

Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell
Benzinga

Wednesday, March 07, 2012

Pressure BioSciences Pops after Positive New Data
Benzinga
New Data Indicate Pressure BioSciences' Novel Technology Platform Offers Great Promise to the Areas of Biomarker Discovery and Drug Development
Benzinga

Thursday, March 01, 2012

Pressure BioSciences Continues Expansion of European Sales Reach With Distribution Agreement for the Benelux Countries
Benzinga

Thursday, February 23, 2012

Pressure Biosciences Spikes Higher on Lebed Promo
Benzinga

Wednesday, January 25, 2012

Pressure BioSciences Reports Significant Progress in the Development of a PCT-based Method to Improve Processing of Sexual Assault Samples
Benzinga

Thursday, January 12, 2012

Benzinga's Microcap Movers for Wednesday January 11, 2012
Benzinga

Monday, December 19, 2011

Pressure BioSciences Announces Distribution Agreement With IUL Instruments GmbH for Germany and Switzerland
Benzinga

Wednesday, November 09, 2011

Pressure BioSciences Announces Registered Direct Offering of Approximately $843K
Benzinga

Tuesday, October 18, 2011

Pressure BioSciences Reports 100% Conversion of Series A and B Preferred Stock Into Common Stock
Benzinga

Thursday, October 13, 2011

Pressure BioSciences Awarded $649,000 Grant From the Department of Defense ("DoD")
Benzinga

Wednesday, September 14, 2011

Pressure BioSciences Files for $15M Mixed Security Shelf
Benzinga

Tuesday, September 06, 2011

Pressure BioSciences, Inc. Awarded NIH SBIR Phase I Grant
Benzinga

Wednesday, June 15, 2011

Pressure BioSciences, Inc. Granted Extension to October 3, 2011 to Regain Compliance With NASDAQ Minimum Stockholders' Equity Requirement
Benzinga

Wednesday, May 25, 2011

Taglich Brothers Neutral On Pressure BioSciences, Inc.
Benzinga

Thursday, April 14, 2011

Morning Market Losers (FFHL, HGSH, PBIO, ABMD)
Benzinga

Wednesday, April 13, 2011

Pressure BioSciences Receives $825,720 as the First Tranche of a $6.0 Million Private Placement
Benzinga

Friday, January 07, 2011

Focus Turns To Biotech Next Week - Analyst Blog
Benzinga
Focus Turns To Biotech Next Week - Analyst Blog
Benzinga
Focus Turns To Biotech Next Week - Analyst Blog
Benzinga
Focus Turns To Biotech Next Week - Analyst Blog
Benzinga
Focus Turns To Biotech Next Week - Analyst Blog
Benzinga
Focus Turns To Biotech Next Week - Analyst Blog
Benzinga

Tuesday, December 14, 2010

Pressure BioSciences (PBIO) Enters New Market with New Products Offering - Analyst Blog
Benzinga
Pressure BioSciences (PBIO) Enters New Market with New Products Offering - Analyst Blog
Benzinga

Wednesday, November 17, 2010

Pressure BioSciences (PBIO) Reports Strong Third Quarter Financial Results - Analyst Blog
Benzinga
Pressure BioSciences (PBIO) Reports Strong Third Quarter Financial Results - Analyst Blog
Benzinga

Tuesday, November 16, 2010

Pressure BioSciences, Inc. Announces Third Quarter EPS of $.26
Benzinga

Friday, November 12, 2010

Pressure Bio Wins New Grant - Analyst Blog
Benzinga
Pressure Bio Wins New Grant - Analyst Blog
Benzinga

Thursday, October 28, 2010

Pressure Bio's 2 Presentations - Analyst Blog
Benzinga

Thursday, August 19, 2010

PBIO: Q2 Better Than Expected; Price Target Raised to $5.00 - Analyst Blog
Benzinga

Monday, August 16, 2010

Pressure BioSciences Offers Unique Technology - Analyst Blog
Benzinga

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

Comments

Loading...